EXOSIRIS
Business purpose.
La recherche, le développement, la conception, la mise au point, l'optimisation et la commercialisation de produits, procédés, services ou technologies innovants dans les domaines de la santé, de l'industrie pharmaceutique, des biotechnologies et de l'immunothérapie
Identity
- Legal form
- SAS, simplified joint-stock company
- Activity
- Other research and experimental development on natural sciences and engineering (72.19Z)
- Sector
- Scientific research and development
- Headcount
- Headcount unknown
- Created
- 3 Jul 2025
- Share capital
- 10,000.00 EUR
- Financial year end
- 31/12
- Establishments
- 1
Directors
- Maria Loustau 46 years old, 06/1980 Directeur general
- Julien Alexis Guillaume Caumartin 49 years old, 01/1977 President de SAS
Related companies
Companies run by the same people. Statutory auditors and liquidators are excluded: they serve in dozens of unrelated companies, and including them would draw groups that do not exist.
- EXOSIRIS INVEST via Maria Loustau
- EXOSIRIS INVEST via Julien Alexis Guillaume Caumartin
Other companies at the same address
7 other company head offices are registered at this address.
Establishments
Financial strength
Financial score
Cannot be computed, not enough data
Confidence: low
formula fin-1.0
Legal score
63 / 100 C
Confidence: high
- No insolvency proceedings
- 40.0 out of 40
- Currently trading
- 20.0 out of 20
- Age (1.4 years)
- 2.7 out of 20
- Accounts filed recently
- 0.0 out of 20
formula leg-1.0
These scores are computed by us from public data, using a published formula. They are not advice, not a guarantee, not a credit decision, and they do not replace a review of the accounts. See how it is calculated
Explore similar companies
Collective agreements
Agreements declared by the employer in its payroll filings.
-
Convention collective nationale de l'industrie pharmaceutique du 6 avril 1956. Etendue par arrêté du 15 novembre 1956 JORF 14 décembre 1956.
IDCC 0176 · repealed · 1 establishment · declared in July 2026
Legal notices
-
Amendment 28 Jul 2026
- Court :
- Greffe du Tribunal des Activités Economiques de Versailles
- Amendment :
- Modification survenue sur le capital.
BODACC B n 20260141, annonce n 5035 · Proof of publication (PDF)
-
Incorporation 20 Jul 2025
- Court :
- Greffe du Tribunal des Activités Economiques de Versailles
BODACC A n 20250137, annonce n 2789 · Proof of publication (PDF)
Filings and accounts
- Formality 16 Jul 2025
Change history
- officer_appointed (empty) → Directeur general 10 Oct 2026
- officer_appointed (empty) → President de SAS 10 Oct 2026
- capital 10307.00 → 10000.00 2 Oct 2026
- registered_address (empty) → 13 Place du Marché 78110 Le Vésinet 1 Oct 2026
- capital (empty) → 10307.00 1 Oct 2026
Frequently asked questions about EXOSIRIS
- What is the SIREN number of EXOSIRIS?
- The SIREN number of EXOSIRIS is 989224969. Its intra-community VAT number is FR77989224969.
- Where is the head office of EXOSIRIS?
- Head office address: 13 PLACE DU MARCHE, 78110 LE VESINET.
- When was EXOSIRIS founded?
- EXOSIRIS was founded on 3 Jul 2025.
- What does EXOSIRIS do?
- Its declared main activity is: Other research and experimental development on natural sciences and engineering (NAF code 72.19Z).
- Who runs EXOSIRIS?
- The officers listed in the register are Maria Loustau (Directeur general), Julien Alexis Guillaume Caumartin (President de SAS).
- Is EXOSIRIS subject to insolvency proceedings?
- No ongoing insolvency proceedings are published in the BODACC for this company.